Patents Assigned to PERFORMANCE LABS PTE. LTD.
  • Compositions and methods for cholesterol, glucose and microbiome control
    Patent number: 11484547
    Abstract: The present invention includes compositions and methods for reducing at least one of fasting blood glucose, total cholesterol, LDL cholesterol, VLDL cholesterol, a cholesterol:HDL ratio, triglycerides, or increasing a healthy microbiome comprising a synergistic amount of a fiber blend, a polyphenol blend, and a multivitamin supplement in an amount sufficient to lower at fasting blood glucose, total cholesterol, LDL cholesterol, VLDL cholesterol, a cholesterol:HDL ratio, triglycerides, or increasing a healthy microbiome.
    Type: Grant
    Filed: January 7, 2019
    Date of Patent: November 1, 2022
    Assignee: PERFORMANCE LABS PTE. LTD.
    Inventor: Daniel Gubler
  • Multivitamin capable of beneficial gene regulation through microRNA (MIRNA)
    Patent number: 10857124
    Abstract: The present invention includes compositions and methods for modifying the expression of microRNAs comprising: one or more plant secondary metabolites capable of beneficially regulating different genes in the human genome by modifying the expression of one or more microRNAs, wherein the one or more plant secondary metabolites are selected and provided in an amount selected to target the modification of one or more specific microRNA.
    Type: Grant
    Filed: August 21, 2019
    Date of Patent: December 8, 2020
    Assignee: PERFORMANCE LABS PTE. LTD.
    Inventor: Daniel Gubler
  • Production of aspirin-triggered resolvins without the use of aspirin in a dietary omega-3 supplement
    Patent number: 10624907
    Abstract: The present invention includes a composition and method of producing aspirin in situ, the method comprising: identifying a subject in need of aspirin or aspirin-like compounds; and providing the subject with a composition comprising: a source of methyl salicylate, an acetyl donor, and L-Arginine, wherein the composition is effective to produce aspirin-triggered resolvins in the subject without the deleterious effect of the aspirin or aspirin-like compounds in the stomach.
    Type: Grant
    Filed: April 12, 2018
    Date of Patent: April 21, 2020
    Assignee: PERFORMANCE LABS PTE. LTD.
    Inventors: Daniel Gubler, Michael Saunders
  • Multivitamin capable of beneficial gene regulation through microRNA (miRNA)
    Patent number: 10426756
    Abstract: The present invention includes compositions and methods for modifying the expression of microRNAs comprising: one or more plant secondary metabolites capable of beneficially regulating different genes in the human genome by modifying the expression of one or more microRNAs, wherein the one or more plant secondary metabolites are selected and provided in an amount selected to target the modification of one or more specific microRNA.
    Type: Grant
    Filed: August 4, 2017
    Date of Patent: October 1, 2019
    Assignee: PERFORMANCE LABS PTE. LTD.
    Inventor: Daniel Gubler